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Previewsother mouse models of CRC are analyzed
at adult stages (>8 weeks). It would be
important to confirm these findings using
different CRC models (e.g., Smad3/)
and also to determine whether the delete-
rious effect of butyrate ismediated through
Gprotein-coupled receptors (Jobin, 2014).
For example, reducing butyrate levels
through dietary manipulation (fiber) or mo-
lecular deletion (Gpr109a/) augmented
polyp formation in ApcMin/+ mice, a phe-
nomenon linked to decreased T regulatory
(Treg) cell differentiation (Singh et al.,
2014).
It is worth noting that this is not the
first instance of a ‘‘butyrate paradox.’’
Butyrate has long been known to have
differential effects on normal versus
cancerous colonocytes, and only recently
has this been addressed. Due to the
Warburg effect, butyrate is metabolized
by cancerous colonocytes to a lesser
extent and therefore accumulates as an
HDAC inhibitor (Donohoe et al., 2012).
Similarly, butyrate may have heteroge-
neous effects on tumorigenesis depend-
ing on host genetic background, the
presence of other bacterial metabolites
such as an omega-3 fatty acid (docosa-hexaenoic acid), which synergizes with
butyrate to induce colonocyte apoptosis
(Kolar et al., 2007), and whether it is
exerting a direct effect on the tumor (cell
autonomous) versus non-cell-autono-
mous effects such as regulating mucosal
immune cell activity as mentioned above.
Therefore, although the current study
contributes to our understanding of the
interplay between diet, microbes, and
CRC, the role of butyrate in cancer pro-
tection/promotion will still require further
investigation. Altering microbial activities
through dietary manipulation represents
an exciting means to harness the micro-
biome and influence health and disease
states. Whether dietary manipulation
could be used effectively to preserve
homeostatic functions afforded by micro-
biota while attenuating its potential
pathological effects is still an open
question, and more research would be
necessary before this strategy becomes
a reality.REFERENCES
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Helminth-induced immunomodulation is thought to influence the outcome of secondary infections. Osborne
et al. (2014) and Reese et al. (2014) demonstrate that helminth infection impacts viral infections by tilting the
immune system toward Th2/M2 immune regulatory responses that dampen Th1/M1 antiviral responses as
well as promote reactivation of latent herpesviruses.The mammalian intestine is home to
many pathogens, including commensal
bacteria, helminth parasites, and viruses.
Among these, helminths represent some
of the earliest recorded human infections
in history and remain a significant source
of infection today. Approximately 2.7
billionpeoplewho live in low-incomecoun-
tries in Africa, South America, and Asia arethought to have some type of helminth
infection (Hotez et al., 2007). In addition
to infectious complications, helminths are
also associated with human malignancy.
S. hematobium is a platyhelminth that is
associated with bladder cancer, particu-
larly in Egypt. Additionally,O. viverrini (liver
fluke) andC. sinesis are classifiedas group
1 carcinogens by the International Agencyfor Research on Cancer (IARC) (Bouvard
et al., 2009) and are causally associated
with cholangiocarcinoma, which is highly
prevalent throughout much of southeast
Asia and Egypt. The presumed mecha-
nisms include chronic inflammation and
hyperplasia of billary epithelium.
Helminth-induced immunomodulation
has long been thought to influence human, August 13, 2014 ª2014 Elsevier Inc. 145
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Previewsimmunity either in a direct fashion or indi-
rectly through modulation of the intestinal
microbiota. The type 2 response is the
arm of the immune system that minimizes
the pathogenesis associatedwith helminth
infection but alsoplays key roles in immune
disorders such as asthma and allergies.
Type 2 responses are characterized by
the induction of CD4+ T helper (Th) 2 cells
and alternatively activated macrophages
(AAMacs) or type 2 macrophages (M2).
The Th2 response is triggered by cyto-
kines; foremost among them are inter-
leukin-4 (IL-4) and IL-13 in addition to IL-5
and IL-9. Through the production of IL-4,
Th2 cells helpB cells secrete immunoglob-
ulin E (IgE). B cells respond to IL-4 via
activation of the IL-4Ra/IL-4Rg receptor
(type I). Macrophages express multiple IL-
4R subunits (type I and type II), which allow
them to respond to IL-4 as well as IL-13,
which can also bind the IL-4R. Upon
receptoractivation,STAT6becomesphos-
phorylated andmoves into the nucleus and
binds to the promoter elements of STAT6
responsive genes. In contrast, Th1 cell re-
sponses, which are generated in response
to most viral infections, result in the secre-
tion of gamma interferon (IFN-g), activation
of macrophages to type 1 macrophages
(M1), and the activation of CD8+ cytotoxic
T cells that can kill virus-infected cells.
These Th1 and Th2 responses can act in
opposition. In particular, IFN-g and IL-4
act antagonistically.
Since helminth infection has such a pro-
found polarizing effect on the mammalian
immune system locally and beyond the
gut-associated lymphoid environment, it
provides a clinically relevant model to
ask questions about polymicrobial inter-
actions: if and how infection with one
pathogen predisposes the host to
respond to subsequent infection with a
second, unrelated pathogen and whether
the life cycle of the secondary pathogen
is altered in any way. The papers by Os-
borne et al. (2014) and Reese et al. (2014)
have examined these questions in the
context of helminth-virus coinfections.
To determine whether helminth infec-
tion directly impacts host immunity or
whether it indirectly affects immunity via
the gut microbiota, Osborne and col-
leagues developed a model of enteric co-
infection using Trichinella spiralis (Ts), a
nematode, which inhabits the small intes-
tine, and amurine norovirus (MNV) that in-
fects the ileum. They report that infection146 Cell Host & Microbe 16, August 13, 2014with Ts elicited a long-lasting inhibition
of antiviral immunity against MNV as well
as influenza, a virus that homes to the
respiratory tract. Thus, helminth-elicited
immunomodulation of antiviral immunity
exists beyond the local environment of
the intestine and can impact antiviral
immunity against virus-infected cells at
distal sites in the human host.
Several theories suggest that, in addi-
tion to direct effects on macrophages
and CD4+ T cells, helminth infection also
modulates host immunity through effects
on the intestinal microbiota. Osborne
et al. (2014) performed sequencing and
phylogenetic analysis of bacterial 16S
rRNA genes of the GI tract following Ts
infection and found that alterations in the
intestinal microbiota did indeed occur
post-Ts infection. However, the degree
of impairment of antiviral responses
against MNV in helminth-infected con-
ventional and germ-free mice was very
similar, revealing that helminth infec-
tion impacts host immune responses
directly and was not dependent on the
microbiota.
The Th2 cytokines induced by helminth
infection are linked to STAT6-dependent
AAMacs, or M2, resulting in the induc-
tion of several AAMac-marker molecules,
including arginase 1 (Arg1) and Ym1
(Chi3l3). Arg1 converts arginine to orni-
thine and urea. Since arginine is also
needed to produce nitric oxide (NO), one
outcome of inducing Arg1 is a dampened
macrophage response to intracellular
pathogens. Ym1 is a chitinase-like protein
that is highly upregulated during Th2
responses. Ym1 is a secreted protein
and hence can modulate the immune
effects of intestinal infection in a systemic
fashion. Osborne et al. discovered that the
AAMacspathway aswell asArg1 andYm1
gene expression were activated in the
intestines of wild-type Ts- and MNV-coin-
fected mice but not STAT6- or IL-4Ra-
deficient animals (Figure 1). The AAMacs
pathway induced upon helminth infection
dampens antiviral responses in a STAT6-
and Th2 cytokine-dependent manner.
The Ts-induced M2 response was domi-
nant over theMNV-inducedM1 response,
although this may be because helminth
infection occurred prior to MNV infection.
Furthermore, these responses were
dependent on IL-4, a cytokine known to
activate the AAMacs pathway, even at
early times post-MNV infection.ª2014 Elsevier Inc.Antibody-mediated neutralization of
Ym1 in Ts- and MNV-coinfected mice re-
sulted in increased CD8+ T cell responses
and increased numbers of virus-specific
CD8+ T cells resulting in enhanced con-
trol of viral replication. Taken together, it
appears that helminth infection directly
modulates host immunity to hinder re-
sponses against viral infection, even at
sites of viral infection distant from the
helminth-infected intestine. Such immu-
nomodulation is independent of the gut
microbiota but is dependent on the acti-
vation of the AAMacs pathway and the in-
hibition of CD8+ antiviral T cell responses
through the action of the Ym1 molecule.
In a related study, Reese et al. (2014)
show that helminth-induced Th2 polariza-
tion can promote viral infections via
a different mechanism. Using helminth-
infected mice that were latently in-
fected with murine gammaherpesvirus
68 (MHV-68), the authors show that the
canonical Th2 and M2 response to hel-
minth infection (Van Dyken and Locksley,
2013) can reactivate latent MHV-68
(Figure 1). This model system allows for
exceptional genetic tools to analyze the
tripartite virus-parasite-host interactions
that cannot be easily studied with the hu-
man-tropic gammaherpesviruses, Kaposi
sarcoma-associated herpesvirus (KSHV),
and Epstein-Barr virus (EBV).
Reeseetal. usedifferentMHV-68mutant
viruses to dissect the mechanism of multi-
ple pathogen interactions in the host. Hel-
minth infection induces the Th2 cytokine
IL-4, which engages the viral transactivator
Rta/Orf50 via Stat6. IL-13,whichalsobinds
the IL-4Ra chain, and Stat6 had the same
phenotypic effect on MHV-68-infected
macrophages. In contrast, helminth infec-
tion of latently infected Stat6 knockout
mice did not result in reactivation. Rta/
Orf50 is necessary and sufficient to initiate
virus reactivation, but MHV-68 reactivation
is subject to negative regulation by IFN-g.
Both IL-4-mediated induction and libera-
tion from IFN-g suppression are needed
in vivo for virus reactivation. Interestingly,
the signaling network needed to induce
MHV-68 reactivation representsonlyasub-
set of the signaling cascade needed for
complete Th2 polarization of bone marrow
macrophages, which supports the idea of
a direct IL-4/Stat6/RTA promoter loop,
rather than the virus responding to cellular
reprogramming as in MHV-68 latently
infected B cells (Siegel et al., 2010).
AB
Figure 1. Helminth Infection Induces Type 2 Immune Responses and the Production of IL-4,
which Effectively Induces the AAMacs Pathway
(A) Summary of the systemic release of YM1 in proximal macrophages and their reprogramming into
AAMacs. This has local as well as systemic consequences resulting in increased susceptibility to intestinal
(norovirus) and respiratory (influenza virus) infection.
(B) Reactivation of latent MHV-68 through a direct interaction between STAT6 and the promoter of the
viral immediate early transactivator RTA (Orf50). IL-4/IL-13 counteracts IFN-g, which normally restricts
MHV-68 reactivation from macrophages.
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PreviewsIL-4 had a similar proreactivation
phenotype in KSHV latently infected
B lymphoma cells in culture, as does
the Th1 cytokine, IFN-g (Chang et al.,
2000). This discordance with regard
to IFN-g is not surprising. B cells are
not macrophages. They are hardwired
to respond differently and to differentstimuli. KSHV reactivation from latent
B cells has been linked to IFN-g
activating the viral IL-6 promoter (Chat-
terjee et al., 2002) and TLR7/TLR8
activation by agonists as well as by sec-
ondary infection with vesicular stomatitis
virus (Gregory et al., 2009; West et al.,
2012).Cell Host & Microbe 16Collectively, these two articles support
the general idea of the vironome as an
integral part of the host. The interrela-
tionships between multiple pathogens
within a host are very complex. A range
of pathogenic outcomes have been
observed with certain other coinfections
such as HIV and tuberculosis (TB).
Perhaps the best-known example with
respect to the herpesviruses is that of
EBV and malaria coinfection in Sub-
Saharan Africa (Torgbor et al., 2014).
The findings from Reese et al. and
Osborne et al. suggest that helminth coin-
fections with viruses may also represent
a significant source of mortality and
morbidity in the human population.ACKNOWLEDGMENTS
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